Related Experiment Video

Updated: Aug 29, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

The role of thymidylate synthase as a molecular biomarker

Antontello DiPaolo, Edward Chu

    Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
    |February 5, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 29, 2026

    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
    08:49

    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

    Published on: January 22, 2019

    Related Concept Videos

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    Therapeutic Drug Monitoring: Affecting Factors01:29

    Therapeutic Drug Monitoring: Affecting Factors

    Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

    Articles linked to this work by shared authors, journal, and citation graph.

    CDK9 inhibition sensitizes intrinsically resistant BRAF V600E mutant colorectal cancer to BRAF inhibitors.

    Acta pharmaceutica Sinica. B·2026

    High-throughput screening for novel drug combinations using patient-derived organoids.

    Biochemical pharmacology·2026

    High-throughput screening identifies NT-1 that synergizes with MRTX1133 against acquired resistant KRASG12D colorectal cancer.

    NPJ precision oncology·2026

    Artificial Intelligence Chatbots and Their Responses to Most Searched Spanish Cancer Questions.

    Cancer medicine·2025

    Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938).

    Cancer·2025

    Targeting YES1 enhances the efficacy of chemotherapy, targeted therapy and onco-immunotherapy.

    Cellular signalling·2025

    Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Adrenergic regulation of cancer immunity.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Focused Ultrasound-Enhanced Drug Delivery to Brain Tumors: Quantitative and Translational Insights from CNS Physiologically Based Pharmacokinetic Modeling.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Role Framing and Trust in Medical AI: Evidence from a Scenario Experiment and EEG.

    Journal of visualized experiments : JoVE·2026

    Artificial Intelligence and Complementary Digital Health Technologies Across the Travel Medicine Continuum: A Narrative Review.

    Journal of travel medicine·2026

    More efficient screening for preclinical Alzheimer's clinical trials using mixture of experts.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

    [Technical medicine in orthognathic surgery: from imaging to surgery].

    Nederlands tijdschrift voor tandheelkunde·2026

    Capturing Pathology Workload Associated With Precision Oncology.

    Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026

    Optimization of protein electrophoresis test orders: results after the implementation of a protocol based on scientific recommendations.

    Advances in laboratory medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us